Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

By afschroeder • August 30, 2026

Hegde SM, Wang X, Bhatia A, Peña-Peña ML, Sherrid MV, Figueiredo EL, Arad M, Barriales-Villa R, Choudhury L, Claggett BL, Coats CJ, de Barros Correia E, Costabel JP, Elliott PM, Silva Enciso JE, Garcia-Pavia P, Ge J, Ho CY, Lakdawala NK, Lewis GD, Maron MS, Martinez MW, Masri A, Maurer MS, Michels M, Mitter SS, Pino Moreno JE, Nagy V, Olivotto I, Owens AT, Poulsen SH, Rader F, Rowin EJ, Ruda M, Schulze PC, Sikand N, Spertus JA, Zhao X, Divanji PH, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Salazar-Mendiguchía J, Wohltman A, Zhuo S, Solomon SD; ACACIA-HCM Investigators. Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy. Circulation. 2026 Aug 29. doi: 10.1161/CIRCULATIONAHA.126.082343. Epub ahead of print. PMID: 42667274.

Tags: aficamten, Cardiology/Epi, cardiomyopathies, cardiomyopathy, Cedars Sinai DoM, Clinical Trial, hypertrophic, Publications

Association of ramus intermedius with greater overall coronary plaque and stenosis burden

Ansari S, Pourafkari L, Kinninger A, Budoff MJ. Association of ramus intermedius with greater overall coronary plaque and stenosis burden. Int J Cardiovasc Imaging. 2026[...]

A Conversation Between Arturo Chiti and Johannes Czernin

Chiti A, Czernin J. A Conversation Between Arturo Chiti and Johannes Czernin. J Nucl Med. 2026 Aug 27:jnumed.126.273671. doi: 10.2967/jnumed.126.273671. Epub ahead of print. PMID:[...]

Non-calcified plaque volume assessed by coronary computed tomographic angiography: prognostic significance, reproducibility, and temporal progression

Ansari S, Budoff MJ. Non-calcified plaque volume assessed by coronary computed tomographic angiography: prognostic significance, reproducibility, and temporal progression. Eur Heart J Imaging Methods Pract.[...]